659 related articles for article (PubMed ID: 31211839)
1. Host Immune Markers Distinguish Clostridioides difficile Infection From Asymptomatic Carriage and Non-C. difficile Diarrhea.
Kelly CP; Chen X; Williams D; Xu H; Cuddemi CA; Daugherty K; Barrett C; Miller M; Foussadier A; Lantz A; Banz A; Pollock NR
Clin Infect Dis; 2020 Mar; 70(6):1083-1093. PubMed ID: 31211839
[TBL] [Abstract][Full Text] [Related]
2. Comparison of Clostridioides difficile Stool Toxin Concentrations in Adults With Symptomatic Infection and Asymptomatic Carriage Using an Ultrasensitive Quantitative Immunoassay.
Pollock NR; Banz A; Chen X; Williams D; Xu H; Cuddemi CA; Cui AX; Perrotta M; Alhassan E; Riou B; Lantz A; Miller MA; Kelly CP
Clin Infect Dis; 2019 Jan; 68(1):78-86. PubMed ID: 29788296
[TBL] [Abstract][Full Text] [Related]
3. Stool Interleukin-1β Differentiates Clostridioides difficile Infection (CDI) From Asymptomatic Carriage and Non-CDI Diarrhea.
Villafuerte Gálvez JA; Pollock NR; Alonso CD; Chen X; Xu H; Wang L; White N; Banz A; Miller M; Daugherty K; Gonzalez-Luna AJ; Barrett C; Sprague R; Garey KW; Kelly CP
Clin Infect Dis; 2023 Feb; 76(3):e1467-e1475. PubMed ID: 35906836
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Intestinal Mycobiota of Patients with Clostridioides difficile Infection among a Prospective Inpatient Cohort.
Cao Y; Wang L; Ke S; Kelly CP; Pollock NR; Villafuerte Gálvez JA; Daugherty K; Xu H; Yao J; Chen Y; Liu YY; Chen X
Microbiol Spectr; 2022 Aug; 10(4):e0136222. PubMed ID: 35867408
[TBL] [Abstract][Full Text] [Related]
5. Two-step Testing for Clostridioides Difficile is Inadequate in Differentiating Infection From Colonization in Children.
Parnell JM; Fazili I; Bloch SC; Lacy DB; Garcia-Lopez VA; Bernard R; Skaar EP; Edwards KM; Nicholson MR
J Pediatr Gastroenterol Nutr; 2021 Mar; 72(3):378-383. PubMed ID: 32925555
[TBL] [Abstract][Full Text] [Related]
6. Ultrasensitive and Quantitative Toxin Measurement Correlates With Baseline Severity, Severe Outcomes, and Recurrence Among Hospitalized Patients With Clostridioides difficile Infection.
Alonso CD; Kelly CP; Garey KW; Gonzales-Luna AJ; Williams D; Daugherty K; Cuddemi C; Villafuerte-Gálvez J; White NC; Chen X; Xu H; Sprague R; Barrett C; Miller M; Foussadier A; Lantz A; Banz A; Pollock NR
Clin Infect Dis; 2022 Jul; 74(12):2142-2149. PubMed ID: 34537841
[TBL] [Abstract][Full Text] [Related]
7. Performance of Clostridium difficile toxin enzyme immunoassay and nucleic acid amplification tests stratified by patient disease severity.
Humphries RM; Uslan DZ; Rubin Z
J Clin Microbiol; 2013 Mar; 51(3):869-73. PubMed ID: 23269736
[TBL] [Abstract][Full Text] [Related]
8. Development and Validation of Digital Enzyme-Linked Immunosorbent Assays for Ultrasensitive Detection and Quantification of Clostridium difficile Toxins in Stool.
Song L; Zhao M; Duffy DC; Hansen J; Shields K; Wungjiranirun M; Chen X; Xu H; Leffler DA; Sambol SP; Gerding DN; Kelly CP; Pollock NR
J Clin Microbiol; 2015 Oct; 53(10):3204-12. PubMed ID: 26202120
[TBL] [Abstract][Full Text] [Related]
9. Toxin Enzyme Immunoassays Detect Clostridioides difficile Infection With Greater Severity and Higher Recurrence Rates.
Guh AY; Hatfield KM; Winston LG; Martin B; Johnston H; Brousseau G; Farley MM; Wilson L; Perlmutter R; Phipps EC; Dumyati GK; Nelson D; Hatwar T; Kainer MA; Paulick AL; Karlsson M; Gerding DN; McDonald LC
Clin Infect Dis; 2019 Oct; 69(10):1667-1674. PubMed ID: 30615074
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of Cycle Threshold, Toxin Concentration, and Clinical Characteristics of Clostridioides difficile Infection in Patients with Discordant Diagnostic Test Results.
Shah MD; Balada-Llasat JM; Coe K; Reed E; Sandlund J; Pancholi P
J Clin Microbiol; 2020 Apr; 58(5):. PubMed ID: 32051264
[No Abstract] [Full Text] [Related]
11. Increased Clinical Specificity with Ultrasensitive Detection of Clostridioides difficile Toxins: Reduction of Overdiagnosis Compared to Nucleic Acid Amplification Tests.
Sandlund J; Estis J; Katzenbach P; Nolan N; Hinson K; Herres J; Pero T; Peterson G; Schumaker JM; Stevig C; Warren R; West T; Chow SK
J Clin Microbiol; 2019 Nov; 57(11):. PubMed ID: 31434726
[No Abstract] [Full Text] [Related]
12. Baseline stool toxin concentration is associated with risk of recurrence in children with
Sandora TJ; Kociolek LK; Williams DN; Daugherty K; Geer C; Cuddemi C; Chen X; Xu H; Savage TJ; Banz A; Garey KW; Gonzales-Luna AJ; Kelly CP; Pollock NR
Infect Control Hosp Epidemiol; 2023 Sep; 44(9):1403-1409. PubMed ID: 36624698
[TBL] [Abstract][Full Text] [Related]
13. Clinical Significance of Toxigenic Clostridioides difficile Growth in Stool Cultures during the Era of Nonculture Methods for the Diagnosis of C. difficile Infection.
Lee CC; Lee JC; Chiu CW; Tsai PJ; Ko WC; Hung YP
Microbiol Spectr; 2021 Oct; 9(2):e0079921. PubMed ID: 34668727
[TBL] [Abstract][Full Text] [Related]
14. Preservation of the Innate Immune Response to
Banegas M; Villafuerte-Gálvez J; Paredes R; Sprague R; Barrett C; Gonzales-Luna AJ; Daugherty K; Garey KW; Xu H; Lin Q; Wang L; Chen X; Pollock NR; Kelly CP; Alonso CD
Open Forum Infect Dis; 2023 Mar; 10(3):ofad090. PubMed ID: 36949876
[TBL] [Abstract][Full Text] [Related]
15. A 2-step algorithm combining glutamate dehydrogenase and nucleic acid amplification tests for the detection of Clostridioides difficile in stool specimens.
Liu C; Tang C; Han Y; Xu Y; Ni F; Jin K; Liu G
Eur J Clin Microbiol Infect Dis; 2021 Feb; 40(2):345-351. PubMed ID: 32944896
[TBL] [Abstract][Full Text] [Related]
16. Reduction in testing and change in testing algorithm associated with decrease in number of nosocomial Clostridioides (Clostridium) difficile infections.
Cook PP; Nichols S; Coogan M; Opera J; DeHart M
Am J Infect Control; 2020 Sep; 48(9):1019-1022. PubMed ID: 32044135
[TBL] [Abstract][Full Text] [Related]
17. Potential underreporting of treated patients using a
Guh AY; Fridkin S; Goodenough D; Winston LG; Johnston H; Basiliere E; Olson D; Wilson CD; Watkins JJ; Korhonen L; Gerding DN
Infect Control Hosp Epidemiol; 2024 May; 45(5):590-598. PubMed ID: 38268440
[TBL] [Abstract][Full Text] [Related]
18. Diagnosis and outcome of Clostridium difficile infection by toxin enzyme immunoassay and polymerase chain reaction in an island population.
Kumar S; Pollok R; Muscat I; Planche T
J Gastroenterol Hepatol; 2017 Feb; 32(2):415-419. PubMed ID: 27505006
[TBL] [Abstract][Full Text] [Related]
19. Detection of Clostridioides difficile toxin B gene: benefits of identifying gastrointestinal pathogens by mPCR assay in the diagnosis of diarrhea in pediatric patients.
Byun JH; Yong D; Kim H
BMC Infect Dis; 2022 Feb; 22(1):126. PubMed ID: 35123434
[TBL] [Abstract][Full Text] [Related]
20. Multicenter study of the epidemiology of Clostridioides difficile infection and recurrence in southern Brazil.
Maestri AC; Raboni SM; Morales HMP; Ferrari LF; Tuon FFB; Losso A; Marconi C; Nogueira KDS
Anaerobe; 2020 Aug; 64():102238. PubMed ID: 32717474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
